Publication

My Pulmonary Research 'Towards novel therapeutic approaches in COPD'

Inhibition of regulated cell death

This article delves into the groundbreaking research led by Prof. Dr. Ken Bracke (Ghent University), a specialist in Pulmonary Diseases, and his team. Focused on COPD, their work accentuates the intricate interplay between cell death, inflammation, and tissue damage. This research significantly advances the COPD discourse by unraveling molecular complexities, laying the groundwork for novel therapeutic strategies.

eu.reca fuels discussions by sharing point of views, research insights and innovations focused on respiratory health. In the 'My Pulmonary Research' series, academic and medical experts share updates on their latest or ongoing research.

Read the article by Prof. dr. Ken Bracke, Department of Respiratory Medicine of the Ghent University, Belgium.

Other publications

How does COVID-19 impact the business of a young and innovative spin-off company active in lung disease assessment?

Point of View 'ArtiQ: AI is making a difference in lung disease assessment'

On the occasion of World Asthma Day today 4 May 2021, we highlight the importance and the extensiveness of the survey outcomes, in our pursuit of an adequate solution to the problems it reveals: a national asthma plan.

Belgium In Urgent Need Of A National Asthma Plan

The SARS-CoV-2 virus can cause severe pneumonia which is different from other pneumonia common seen in the hospital.